Sentry BioPharma Services ApS

CVR 41330619 · Private limited company (ApS) · Active · Medium risk

Sentry BioPharma Services ApS is a Private limited company (ApS), founded on , based in København K. The company is registered in the industry oplagring og opbevaring. Our model estimates a bankruptcy risk of 1.4% over the next 12 months, which is 1.0 times the average for Danish companies. 6 annual reports have been published, of which 2 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK -11.6m and a net result of DKK -538k. CEO: Timothy Jon Mitchell, William Maxwell Tuttle.

Bankruptcy risk for Sentry BioPharma Services ApS

1.4%
probability of bankruptcy within 12 months
Medium risk

1.0 × the average (1.41%) · higher risk than 75% of active Danish companies

Lowest riskHighest risk

Increases the risk

Moves in the last 2 years2 · bankruptcy rate 23.9%2.7×
Equity ratio< -50% · bankruptcy rate 19.3%2.2×
Negative equityYes · bankruptcy rate 17.5%2.0×
Equity vs. share capital< 0× · bankruptcy rate 17.3%2.0×
Auditor's statementNo assurance · bankruptcy rate 13.2%1.5×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
Time at current address< 0.5 yrs · bankruptcy rate 12.0%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×

Reduces the risk

Reporting classReporting class B · bankruptcy rate 3.2%0.37×
Number of CEOs2 · bankruptcy rate 5.7%0.65×
Return on assets-20%–0% · bankruptcy rate 6.2%0.70×
Published annual reports5–10 · bankruptcy rate 6.3%0.72×
Going-concern uncertaintyNo · bankruptcy rate 6.4%0.73×
Age (years)5–10 yrs · bankruptcy rate 7.0%0.80×
Qualification / emphasis of matterNo · bankruptcy rate 7.1%0.80×
Restated annual reports1 · bankruptcy rate 7.1%0.81×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
41330619
Status
Active
Company type
Private limited company (ApS)
Founded
(6 years)
Address
c/o Citco (Denmark) ApS, August Bournonvilles Passage 1
1055 København K
Municipality
København
Industry
Oplagring og opbevaring (521000)
Bankruptcies in the industry: Speditører
Share capital
DKK 40k
Audit opted out
Yes

Warning signs

Annual reports filed late2 of 6
Missing annual reportNo
Negative equityYes
Equity ratio-79.6%
Current ratio45%
Moves (last 2 years)2
CEO changes in total3
CEO's previous bankruptcies0
Other companies at the address122
Going-concern uncertaintyNo

Financials and key figures

Financial year202520242023
Net profitDKK -538kDKK -3.3mDKK -3.6m
EquityDKK -11.6mDKK -11.1mDKK -7.8m
Total assetsDKK 14.6mDKK 4.6mDKK 3.8m
CashDKK 1.7mDKK 321k–
Short-term debtDKK 26.2mDKK 15.7m–
Tax owedDKK 1.2mDKK 22k–
Avg. employees0––

Latest annual report: Reporting class B · auditor's statement: No audit assistance.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025177
1 Jan 2024 – 31 Dec 2024196 Late
1 Jan 2023 – 31 Dec 2023194 Late
1 Jan 2022 – 31 Dec 2022178
1 Jan 2021 – 31 Dec 2021180
27 Apr 2020 – 31 Dec 2020181

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOTimothy Jon MitchellCurrent
CEOWilliam Maxwell TuttleCurrent
CEOOle Meier Sørensen
Owner (100%)Sentry BioPharma Services, Inc.Current
FounderSentry BioPharma Services, Inc.Current

The CEOs' other companies

Ole Meier Sørensen – 53 other companies, of which 13 bankrupt

Address history (4 moves)

c/o Citco (Denmark) ApS, August Bournonvilles Passage 1, 1055 København K
August Bournonvilles Passage 1, 1055 København K
c/o Citco (Denmark) ApS, Nybrogade 12, 1203 København K
c/o Citco (Denmark) ApS, Holbergsgade 14, 2. tv, 1057 København K
c/o Plesner Advokatpartnerselskab, Amerika Plads 37, 2100 København Ø

Other companies at the same address

Similar companies in København

Questions and answers about Sentry BioPharma Services ApS

Has Sentry BioPharma Services ApS gone bankrupt?

No, Sentry BioPharma Services ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Sentry BioPharma Services ApS?

Our model estimates a bankruptcy risk of 1.4% over the next 12 months (medium risk), which is 1.0 times the average for Danish companies.

Who is the CEO of Sentry BioPharma Services ApS?

Timothy Jon Mitchell, William Maxwell Tuttle are the CEOs of Sentry BioPharma Services ApS.

When was Sentry BioPharma Services ApS founded?

Sentry BioPharma Services ApS was founded on 27 April 2020.

What is the equity of Sentry BioPharma Services ApS?

Equity was DKK -11.6m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.